If J&J really wants to support nurses, it should make the TB drug bedaquiline affordable
Bedaquiline, an important treatment for tuberculosis, costs too much for most people. Johnson & Johnson could sell it for $1 a day and still turn a profit. More
‘They killed her’: Why are breast implants still putting millions of women at risk?
Allergan’s “medical aesthetics” products helped persuade AbbVie to buy the company. But what if the devices driving profit are also endangering women’s health? More
Hospitals Knew How to Make Money. Then Coronavirus Happened.
Surgeries are canceled. Business models are shifting. Some of the hardest-hit hospitals may close, leaving patients with fewer options for care. More
The Nonprofit Grifters Who Want a Cut of the Coronavirus Bailout
After years of undermining health policy to aid their Big Pharma patrons, patient advocacy groups are making claims to federal pandemic relief. More
Hospital workers complain of minimal disclosure after COVID exposures
The disconnect between hospital policy and worker expectations often centers around the lack of clear, direct communication with individual workers who have been potentially exposed to the coronavirus. More
Pandemic spawns new spirit of collaboration for Boston’s longtime rival hospitals
Hospitals have been sharing supplies, equipment, data, and even staff as they scramble to treat patients sick with COVID-19, the disease caused by the coronavirus. More
One Hospital System’s Response to Covid-19? Union-Busting.
Administrators across the country are increasingly turning to anti-labor consultants to fend off nurses’ unions. More
Hospital CEOs take pay cuts amid COVID-19
As losses mount, hospital chains like Advocate Aurora Health, Providence and Loyola Medicine have had to trim costs—including at the top. More
Commercial Influences on Electronic Health Records and Adverse Effects on Clinical Decision Making
This Viewpoint describes how the clinical decision support tools that are part of electronic health records and are used by physicians may be corrupted by commercial influence. More
Florida oncology network that bilked cancer patients gets $67 million in COVID-19 aid
Florida Cancer Specialists said that coronavirus relief dollars from taxpayers will not be used to pay back their fines. More
As Hospitals Lose Revenue, More Than A Million Health Care Workers Lose Jobs
Faced with lost revenue from canceled elective procedures, hospitals laid off 1.4 million health care workers in April, including nearly 135,000 from hospitals. More
Are high drug prices buying us the most effective treatments?
The pharmaceutical industry often justifies high drug prices by claiming that they create more innovation, but two recent studies find that drug costs and clinical benefit are often not related. More
How COVID-19 is exposing — and widening — cracks in the US health system
Structural racism created the unequal conditions driving the black-white health gap. Disparities in COVID-19 infection and death rates show just how dire that gap is. More
I’m a nurse in a Covid-19 unit. My hospital’s leaders frighten me more than the virus
Despite the direct and personal care that nurses provide, they are not valued as they should be. That's a shame, and maybe even a deadly shame. More
Financial Toxicity After Acute Respiratory Distress Syndrome
The financial burdens and subsequent related distress of medical care, referred to as financial toxicity, may limit access to beneficial treatments. More
U.S. coronavirus stimulus went to some healthcare providers facing criminal inquiries
Eager to bolster the healthcare system during the coronavirus pandemic, the U.S. government last month sped $30 billion in stimulus payments to most healthcare providers that billed Medicare last year. More
As coronavirus infections peak, profit-driven hospital systems must be held accountable
Vulnerable populations are on the losing end of too many decisions in health care. More
One Thing the Pandemic Hasn’t Stopped: Aggressive Medical-Debt Collection
U.S. hospitals are in the spotlight for being on the frontline of fighting the pandemic. But in the shadows, debt collection operations continue, often by the same institutions treating coronavirus patients, all while unemployment and uncertainty soar. More
Amid Coronavirus Distress, Wealthy Hospitals Hoard Millions
As the coronavirus wreaks havoc with hospital finances, wealthy hospitals sitting on millions or even billions of dollars are in a competitive stampede against near-insolvent hospitals for the same limited pots of financial relief. More
Poll: Cost makes nearly 1 in 10 leery of seeking COVID care
As states gear up to reopen, a poll finds a potential obstacle to controlling the coronavirus: nearly 1 in 10 adults say cost would keep them from seeking help if they thought they were infected. More